M's Science and Eisai Sign Option Agreement for Sigma Agonist SA4503
14-Mar-2008 -
M's Science Corporation and Eisai Co., Ltd. announced that the companies entered into an option agreement for SA4503, a novel sigma agonist which is being developed by M's Science in Europe for the treatment of depression and post-stroke therapy.
Under the terms of the agreement, M's Science ...
central nervous system
depressions
diseases
+4